
GPT Healthcare (GPTHEALTH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.1B
Gross Profit
660.2M
61.63%
Operating Income
111.8M
10.44%
Net Income
76.8M
7.17%
EPS (Diluted)
₹0.94
Balance Sheet Metrics
Total Assets
3.8B
Total Liabilities
1.4B
Shareholders Equity
2.5B
Debt to Equity
0.55
Cash Flow Metrics
Revenue & Profitability Trend
GPT Healthcare Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 4.1B | 4.0B | 3.6B | 3.4B | 2.4B |
Cost of Goods Sold | 1.5B | 1.5B | 1.3B | 1.4B | 989.3M |
Gross Profit | 2.6B | 2.5B | 2.3B | 2.0B | 1.4B |
Gross Margin % | 63.8% | 63.1% | 62.9% | 58.1% | 59.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 121.2M | 72.8M | 80.0M | 43.6M | 60.4M |
Other Operating Expenses | 480.7M | 449.2M | 435.6M | 402.7M | 344.8M |
Total Operating Expenses | 601.9M | 522.0M | 515.6M | 446.4M | 405.2M |
Operating Income | 671.2M | 720.6M | 594.4M | 605.2M | 377.9M |
Operating Margin % | 16.5% | 18.0% | 16.5% | 18.0% | 15.6% |
Non-Operating Items | |||||
Interest Income | 46.2M | 36.0M | 38.8M | 39.7M | 39.4M |
Interest Expense | 25.3M | 64.9M | 84.4M | 101.9M | 127.6M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 693.5M | 680.4M | 559.7M | 540.8M | 288.8M |
Income Tax | 194.2M | 202.7M | 169.6M | 124.2M | 77.9M |
Effective Tax Rate % | 28.0% | 29.8% | 30.3% | 23.0% | 27.0% |
Net Income | 499.2M | 477.7M | 390.1M | 416.6M | 210.9M |
Net Margin % | 12.3% | 12.0% | 10.8% | 12.4% | 8.7% |
Key Metrics | |||||
EBITDA | 927.1M | 940.5M | 786.9M | 777.4M | 547.4M |
EPS (Basic) | ₹6.08 | ₹5.96 | ₹4.87 | ₹5.08 | ₹2.57 |
EPS (Diluted) | ₹6.08 | ₹5.96 | ₹4.75 | ₹5.08 | ₹2.57 |
Basic Shares Outstanding | 82054823 | 80098187 | 82054823 | 82054823 | 82054823 |
Diluted Shares Outstanding | 82054823 | 80098187 | 82054823 | 82054823 | 82054823 |
Income Statement Trend
GPT Healthcare Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 16.6M | 16.9M | 66.0M | 82.7M | 47.8M |
Short-term Investments | 319.8M | 173.4M | 102.8M | 53.9M | - |
Accounts Receivable | 197.0M | 242.8M | 206.8M | 134.3M | 172.6M |
Inventory | 88.2M | 81.5M | 89.2M | 72.8M | 64.3M |
Other Current Assets | 22.7M | 15.6M | - | - | - |
Total Current Assets | 788.2M | 801.6M | 812.7M | 856.9M | 863.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.3B | 38.0K | 38.0K | 40.0K | 40.0K |
Goodwill | 9.9M | 8.5M | 3.9M | 460.0K | 810.0K |
Intangible Assets | 9.9M | 8.5M | 3.9M | 460.0K | 810.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 40.5M | 6.7M | - | - | - |
Total Non-Current Assets | 3.1B | 2.7B | 2.5B | 2.4B | 2.3B |
Total Assets | 3.8B | 3.5B | 3.3B | 3.2B | 3.2B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 347.6M | 373.9M | 333.9M | 289.3M | 258.9M |
Short-term Debt | 125.7M | 115.7M | 256.0M | 241.3M | 212.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.7M | 967.0K | 767.0K | 420.0K | 470.0K |
Total Current Liabilities | 742.4M | 772.1M | 818.4M | 684.8M | 600.0M |
Non-Current Liabilities | |||||
Long-term Debt | 227.3M | 189.7M | 567.5M | 774.2M | 1.0B |
Deferred Tax Liabilities | 192.8M | 119.6M | 35.7M | 0 | 0 |
Other Non-Current Liabilities | 107.0M | 113.4M | - | - | - |
Total Non-Current Liabilities | 621.6M | 498.2M | 795.5M | 965.7M | 1.2B |
Total Liabilities | 1.4B | 1.3B | 1.6B | 1.7B | 1.8B |
Equity | |||||
Common Stock | 820.5M | 820.5M | 799.0M | 799.0M | 179.4M |
Retained Earnings | 887.5M | 593.9M | 437.8M | 366.0M | 123.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.5B | 2.2B | 1.7B | 1.6B | 1.3B |
Key Metrics | |||||
Total Debt | 353.0M | 305.4M | 823.6M | 1.0B | 1.3B |
Working Capital | 45.7M | 29.5M | -5.8M | 172.1M | 263.3M |
Balance Sheet Composition
GPT Healthcare Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 693.5M | 680.4M | 559.7M | 540.8M | 288.8M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -25.1M | -130.0M | -45.4M | -700.0K | -44.9M |
Operating Cash Flow | 631.6M | 569.9M | 553.1M | 601.8M | 324.7M |
Investing Activities | |||||
Capital Expenditures | -494.4M | -192.2M | -84.9M | -103.9M | -61.2M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -191.0M | -360.7M | -100.0M | -342.0M | -110.0K |
Investment Sales | 198.4M | 141.5M | 54.4M | 243.9M | 0 |
Investing Cash Flow | -487.0M | -411.4M | -130.5M | -202.0M | -61.3M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -287.2M | -239.7M | -319.6M | -172.6M | -134.4M |
Debt Issuance | 94.0M | 0 | 2.4M | 0 | 184.2M |
Debt Repayment | -87.5M | -527.7M | -300.3M | -288.8M | -100.5M |
Financing Cash Flow | -278.6M | -365.9M | -630.9M | -447.4M | -73.9M |
Free Cash Flow | 174.7M | 494.3M | 564.1M | 554.2M | 369.5M |
Net Change in Cash | -134.0M | -207.4M | -208.3M | -47.6M | 189.4M |
Cash Flow Trend
GPT Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
25.32
Forward P/E
15.82
Price to Book
4.88
Price to Sales
2.90
PEG Ratio
-1.13
Profitability Ratios
Profit Margin
11.44%
Operating Margin
10.44%
Return on Equity
20.14%
Return on Assets
12.99%
Financial Health
Current Ratio
1.06
Debt to Equity
14.24
Per Share Data
EPS (TTM)
₹5.82
Book Value per Share
₹30.21
Revenue per Share
₹50.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
gpthealth | 12.1B | 25.32 | 4.88 | 20.14% | 11.44% | 14.24 |
Max Healthcare | 1.1T | 95.44 | 11.55 | 11.47% | 15.27% | 32.09 |
Apollo Hospitals | 1.1T | 68.67 | 13.06 | 16.71% | 6.98% | 90.89 |
Indraprastha Medical | 42.3B | 24.33 | 6.84 | 26.98% | 12.21% | 5.49 |
Shalby | 28.4B | 1,122.67 | 2.60 | 0.63% | -0.05% | 47.82 |
Dr. Agarwal's Eye | 23.5B | 40.35 | 11.14 | 26.07% | 13.96% | 158.94 |
Financial data is updated regularly. All figures are in the company's reporting currency.